Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD

Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD have?

Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD has 212 citations in the OpenAlex counts ScholarIQ stores.

When was Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD published?

Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD has 2004 year in the ScholarIQ index.

What is the open-access status of Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD?

Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD has closed oa status in the ScholarIQ index.

What is the DOI of Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD?

The DOI for Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD is on the source record.

What is the PMID of Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD?

The PMID for Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD is on the source record.

What is the OpenAlex record for Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD?

The OpenAlex for Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD is on the source record.